Cargando…
Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson’s disease models
Parkinson is a common neurodegenerative disorder, characterized by motor and non-motor symptoms, including abnormalities in the gut function, which may appear before the motor sign. To date, there are treatments that can help relieve Parkinson’ disease (PD)-associated symptoms, but there is no cure...
Autores principales: | Castelli, Vanessa, d’Angelo, Michele, Lombardi, Francesca, Alfonsetti, Margherita, Antonosante, Andrea, Catanesi, Mariano, Benedetti, Elisabetta, Palumbo, Paola, Cifone, Maria Grazia, Giordano, Antonio, Desideri, Giovambattista, Cimini, Annamaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093198/ https://www.ncbi.nlm.nih.gov/pubmed/32155131 http://dx.doi.org/10.18632/aging.102927 |
Ejemplares similares
-
Probiotic DSF counteracts chemotherapy induced neuropathic pain
por: Castelli, Vanessa, et al.
Publicado: (2018) -
Neuroprotective effects of the PPARβ/δ antagonist GSK0660 in in vitro and in vivo Parkinson’s disease models
por: Antonosante, Andrea, et al.
Publicado: (2023) -
PPARα-Selective Antagonist GW6471 Inhibits Cell Growth in Breast Cancer Stem Cells Inducing Energy Imbalance and Metabolic Stress
por: Castelli, Vanessa, et al.
Publicado: (2021) -
The Role of Stiffness in Cell Reprogramming: A Potential Role for Biomaterials in Inducing Tissue Regeneration
por: d’Angelo, Michele, et al.
Publicado: (2019) -
The emerging role of probiotics in neurodegenerative diseases: new hope for Parkinson’s disease?
por: Castelli, Vanessa, et al.
Publicado: (2020)